Germany· DE-A57-2d2408ad8b4f8dca
Dimetinden Aristo Aristo
A dimetindene product containing dimetindene maleate, registered in Germany by Aristo Pharma Gmbh (Art 57). The same ATC class is registered in 6 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Dimetindene is registered in 6 of 19 countries.
Countries holding a registration under ATC D04AA13 (dimetindene), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 4 of them publish a price we can compare per daily dose
Dimetindene · ATC D04AA13
6 / 19 countries
- Czechiaprice
- Germany
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Dimetindene Maleate
- Manufacturer
- Aristo Pharma Gmbh (Art 57)
- Country
- Germany (DE)
- ATC code
- D04AA13
- ATC class
- Dimetindene
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D04AA13
Dimetindene, as other registers publish it.
- PolandAleric ŻelUS Pharmacia Sp. z o.o.
- PolandALLERTEC FOXILLZakłady Farmaceutyczne POLPHARMA S.A.
- CzechiaBELDIMETBELUPO lijekovi i kozmetika, d.d., Koprivnica
- CzechiaBELDIMETBELUPO lijekovi i kozmetika, d.d., Koprivnica
- PolandDimastinZIAJA Ltd Zakład Produkcji Leków Sp. z o.o.
- GermanyDimestilGrindeks
- GermanyDimetin AdgcZentiva Pharma Gmbh
- GermanyDimetinden AlAliud Pharma Gmbh
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3ad21fa8-c8d4-4bbf-aac0-c1bd77c47830 GET /v1/drugs/3ad21fa8-c8d4-4bbf-aac0-c1bd77c47830?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Dimetindene Maleate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about dimetindene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.